
Source briefing
Medicine shortages and availability issues: guidance for companies
Medicine shortages and availability issues: guidance for companies
Read →
Source briefing
Human Myiasis Resulting from Reemergence of Cochliomyia hominivorax Screwworm, Mexico, 2025–2026
O. Delgado-Cuellar et al.
Read →
Source briefing
Human medicines European public assessment report (EPAR): Kisqali, ribociclib, Date of authorisation: 22/08/2017, Revision: 27, Status: Authorised
Human medicines European public assessment report (EPAR): Kisqali, ribociclib, Date of authorisation: 22/08/2017, Revision: 27, Status: Authorised
Read →
Source briefing
Human medicines European public assessment report (EPAR): Vantobra (previously Tobramycin PARI), tobramycin, Date of authorisation: 18/02/2019, Revision: 7, Status: Authorised
Human medicines European public assessment report (EPAR): Vantobra (previously Tobramycin PARI), tobramycin, Date of authorisation: 18/02/2019, Revision: 7, Status: Authorised
Read →
Source briefing
Human medicines European public assessment report (EPAR): Caprelsa, vandetanib, Date of authorisation: 16/02/2012, Revision: 32, Status: Authorised
Human medicines European public assessment report (EPAR): Caprelsa, vandetanib, Date of authorisation: 16/02/2012, Revision: 32, Status: Authorised
Read →
Source briefing
Human medicines European public assessment report (EPAR): Orblid, bevacizumab, Status: Application withdrawn
Human medicines European public assessment report (EPAR): Orblid, bevacizumab, Status: Application withdrawn
Read →
Source briefing
Human medicines European public assessment report (EPAR): Twinrix Adult, hepatitis A (inactivated) and hepatitis B (rDNA) (HAB) vaccine (adsorbed), Date of authorisation: 19/09/1996, Revision: 25, Status: Authorised
Human medicines European public assessment report (EPAR): Twinrix Adult, hepatitis A (inactivated) and hepatitis B (rDNA) (HAB) vaccine (adsorbed), Date of authorisation: 19/09/1996, Revision: 25, Status: Authorised
Read →
Source briefing
Ninth European Medicines Agency (EMA) and EFPIA bilateral meeting, Online, European Medicines Agency, Amsterdam, the Netherlands, from 16 September 2026, 10:30 (CEST) to 16 September 2026, 12:30 (CEST)
Ninth European Medicines Agency (EMA) and EFPIA bilateral meeting, Online, European Medicines Agency, Amsterdam, the Netherlands, from 16 September 2026, 10:30 (CEST) to 16 September 2026, 12:30 (CEST)
Read →
Source briefing
Fifth European Medicines Agency (EMA) and Affordable Medicines Europe bilateral meeting, Online, European Medicines Agency, Amsterdam, the Netherlands, 11 September 2026
Fifth European Medicines Agency (EMA) and Affordable Medicines Europe bilateral meeting, Online, European Medicines Agency, Amsterdam, the Netherlands, 11 September 2026
Read →
Source briefing
European platform for regulatory science research meeting: October 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 22 October 2026, 09:00 (CEST) to 22 October 2026, 17:00 (CEST)
European platform for regulatory science research meeting: October 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 22 October 2026, 09:00 (CEST) to 22 October 2026, 17:00 (CEST)
Read →